Literature DB >> 7813541

Ranitidine-induced bradycardia in a neonate--secondary to congenital long QT interval syndrome?

P Alliët, E Devos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813541     DOI: 10.1007/bf01954504

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  9 in total

1.  Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death.

Authors:  A JERVELL; F LANGE-NIELSEN
Journal:  Am Heart J       Date:  1957-07       Impact factor: 4.749

2.  Different histamine actions in proximal and distal human coronary arteries in vitro.

Authors:  M Keitoku; Y Maruyama; T Takishima
Journal:  Cardiovasc Res       Date:  1990-08       Impact factor: 10.787

3.  Torsades de Pointes after treatment with terfenadine and ketoconazole.

Authors:  M Zimmermann; H Duruz; O Guinand; O Broccard; P Levy; D Lacatis; A Bloch
Journal:  Eur Heart J       Date:  1992-07       Impact factor: 29.983

4.  Ranitidine and bradycardia.

Authors:  W S Johnson; D R Miller
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

5.  Bradycardia and neurologic disorders associated with ranitidine in a child.

Authors:  P Balestrazzi; G Gregori; S Bernasconi; G Giovannelli
Journal:  Am J Dis Child       Date:  1985-05

6.  Idiopathic long QT syndrome: progress and questions.

Authors:  P J Schwartz
Journal:  Am Heart J       Date:  1985-02       Impact factor: 4.749

7.  Cardiovascular effects of H2-receptor antagonists.

Authors:  D G Hughes; E A Dowling; R E DeMeersman; W R Garnett; H T Karnes
Journal:  J Clin Pharmacol       Date:  1989-05       Impact factor: 3.126

8.  Ranitidine-induced bradycardia in a neonate--a first report.

Authors:  E Nahum; O Reish; N Naor; P Merlob
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

9.  Hemodynamic effects of different H2-receptor antagonists.

Authors:  H Hinrichsen; A Halabi; W Kirch
Journal:  Clin Pharmacol Ther       Date:  1990-09       Impact factor: 6.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.